Skip to main content

Advertisement

SpringerLink
Log in

Highlights of the Annual Congress of the European Association of Nuclear Medicine, Amsterdam 2003

  • Review Article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14A–C
Fig. 15
Fig. 16
Fig. 17
Fig. 18

References

  1. Tang T, Branle F, De Witte O, Sadeghi N, Wikler D, Golsman S. PET-methionine for chemotherapy evaluation in low-grade oligodendroglioma. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S190 (abstract 199).

    Google Scholar 

  2. Boán JF, Rodriguez M, Serra P, Arbea L, Arbizu J, Aristu J, Peñuelas I, Richter JA. Combined evaluation of18F-FDG and 11C-methionine PET in the management of previously treated brain tumors. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S190 (abstract 197).

    Google Scholar 

  3. Grönroos T, Lehtiö K, Söderström KO, Eskola O, Viljanen T, Grénman R, Minn H. Flow, metabolism and hypoxia in squamous-cell carcinoma of the head and neck: correlation between multiple immunohistochemical parameters and PET. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S159 (abstract 45).

    Google Scholar 

  4. Van de Wiele C, Lahorte C, Vermeersch H, Loose D, Merville K, Steinmetz N, Vanderheyden JL, Cuenelier C, Slegers G, Dierckx R. Quantitative tumour apoptosis imaging using99mTc-Hynic annexin single photon emission computerized tomography. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S180 (abstract 144).

    Google Scholar 

  5. Tobuert ME, Darsin-Bettinger D, Cassinat B, Tenenbaum F, Corone C, Rain JD, Chomienne C. Redifferentiation therapy with retinoids for radioiodine negative thyroid cancer patients. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2): S172 (abstract 106).

  6. Rubello D, Pavan D, Piotto A, Pagetta C, Pelizzo MR, Sotti G, Muzzio PC, Casara D. Radio-guided surgery in patients with131I negative recurrent thyroid cancer: intra-operative procedure and clinical results. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S155 (abstract 24).

    Google Scholar 

  7. Kienast O, Dudczak R, Peck-Radosavljevic M, Kurtaran A, Becherer A, Angelberger P, Li S. Visualisation of follicular thyroid carcinoma metastases by123I-vascular endothelial growth factor-165 (123I-VEGF165) receptor scintigraphy. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2): S286 (abstract P210).

  8. Corsetti F, Chianelli M, Cornelissen B, Van de Wiele C, D’Alessandria C, Slegers G, Mather SJ, Scopinaro F, Di Mario U, Filetti S, Signore A. A new radiopharmaceutical for the study of metastatic differentiated thyroid carcinoma: radiolabelled rhTSH. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S324 (abstract P412).

    Google Scholar 

  9. Schillaci O, Spanu A, Scopinaro F, Monteleone F, Solinas ME, Pirina P, Marongiu P, Madeddu G, Ginesu F, Madeddu G.99mTc-tetrofosmin (TF) SPET in non small cell lung carcinoma (NSCLC) mediastinal lymph node staging. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S287 (abstract P215).

    Google Scholar 

  10. Steinert HC, Brack T, Gaspert A, Schneiter D, Weder W, Lardinois D. Non-small cell lung cancer: sentinel lymph-node identification and sampling after bronchoscopic radioisotope application. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S233 (abstract 400).

    Google Scholar 

  11. Meisetschlaeger G, Scheidhauer K, Wester HJ, Schottelius M, Herz M, Stahl A, Schwaiger M. A novel fast18F-labeled octreotide analogue: comparison of Nα-(1-deoxy-D-fructosyl)-Nε-(2-fluoropropionyl)-Lys0-Tyr3-octreotate (FP-Gluc-TOCA) –PET and 111In-Octrotide-SPECT. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S204 (abstract 258).

    Google Scholar 

  12. Montravers F, Younsi N, Kerrou K, Grahek D, Aide N, Jacob T, Balogova S, de Beco V, Colombet C, Talbot JN.18F-DOPA-PET for tumour detection in patients with neuroendocrine digestive tumours: preliminary results. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S203 (abstract 255).

    Google Scholar 

  13. Parisella MG, D’Alessandria C, van den Bossche B, Chianelli M, Mikolajczak R, Maecke H, Scopinaro F, Signore A.99mTc-EDDA/HYNIC-TOC: a new octreotide derivative in the follow up of medullary thyroid carcinoma: comparison with other imaging modalities. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S237 (abstract 422).

    Google Scholar 

  14. Muehllechner P, Gabriel M, Decristoforo C, Kendler D, Heute D, Donnemiller E, Moncayo R. Somatostatin receptor scintigraphy using99mTc-EDDA-HYNIC-TOC in patients with medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S285 (abstract P203).

    Google Scholar 

  15. Paganelli G, Viale G, Luini A, Galimberti V, Veronesi P, Robertson C, Trifirò G, De Cicco C, De Lucia F, Veronesi U. Sentinel node biopsy compared to routine axillary dissection in carcinoma of the breast. Five years follow-up of a randomized trial. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S234 (abstract 406).

    Google Scholar 

  16. Estourgie SH, Valdés Olmos RA, Nieweg OE, Rutgers EJT, Kroon BBR, Hoefnagel CA. Lymphatic drainage patterns from the breast. 700 patients with palpable or non-palpable lesions. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S236 (abstract 416).

  17. Dorn R, Wawroschek F, Vogt H, Wengenmair H, Gröber S, Harzmann R, Sciuk J. Lymphoscintigraphy and sentinel lymph node (SLN) identification in prostate cancer: results from 350 patients. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S153 (abstract 15).

    Google Scholar 

  18. Scopinaro F, De Vincentis G, Soluri A, Di Santo G, Remediani S, Scafè R, Mangano AM, Ruco L, Mattei M. Driving mammotome biopsy with image fusion between digital X-ray mammography and high resolution scintigraphy with sestamibi or bombesin. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S289 (abstract P228).

    Google Scholar 

  19. Tsuchimochi M, Hayama K, Katada T, Oda T, Harada M, Sasaki Y, Toyama M, Yamaguchi A, Mataga I, Tsuchikawa K, Sakahara H. Imaging of sentinel nodes by using a prototype of small semiconductor gamma camera in patients with oral cancer. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S350–351 (abstract P557).

    Google Scholar 

  20. Schiepers C, Yap CS, Quon A, Giuliano P, Silverman DH, Dahlbom M, Phelps ME, Ratib O, Czernin J. Added value of PET/CT for cancer staging and lesion localization. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S227–228 (abstract 371).

    Google Scholar 

  21. Reinhardt MJ, Jaeger U, Matthies A, Textor HJ, Risse J, von Mallek D, Joe A, Nonn S, Distelmaier M, Schild HH, Biersack HJ, Tueting T. First results of combined PET/CT imaging in melanoma patients—impact of image fusion on accurate diagnosis. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S169 (abstract 90).

    Google Scholar 

  22. Blumstein NM, Feigl F, Wahl A, Gottfried HW, Glatting G, Reske SN. Is11C-choline PET/CT better than TRUS-guided biopsy for detecting prostate cancer? Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S193 (abstract 214).

    Google Scholar 

  23. Blumstein NM, Karges W, Motthaghy FM,Röschmann N, Wahl A, Böhm BO, Reske SN.18F-DOPA PET/CT improves surgical therapy and therapy monitoring in patients with neuroendocrine tumors. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S204 (abstract 256).

  24. Tutus A, Kula M, Topsakal R, Basbug M, Ergin A. Comparison of acute oral trimetazidine administration with nitrate infusion in predicting postrevascularization recovery: evaluation with gated technetium-99m tetrofosmin SPET. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S257 (abstract P55).

    Google Scholar 

  25. Knuuti J, Sundell J, Koistinen J, Ylitalo A, Naum A, Stolen KQ, Kalliokoski R, Nekolla SG, Airaksinen J, Bax JJ. The effects of cardiac resynchronization therapy on myocardial energetics and metabolic reserve in patients with dilated cardiomyopathy. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S170 (abstract 95).

    Google Scholar 

  26. Prior JO, Wu HM, Hernandez-Pampaloni M, Inubushi M, Schindler TH, Facta AD, Quiñones MJ, Bischof Delaloye A, Hsueh WA, Huang SH, Schelbert HR. Is coronary circulatory dysfunction a component of the insulin resistance syndrome? A factor analysis using PET myocardial blood flow measurement in response to adenosine and cold pressor test. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S192 (abstract 207).

    Google Scholar 

  27. Pellegrino T, Storto G, Silvestro A, Sorrentino AR, De lauro F, Perrone Filardi P, Brevetti G, Cuocolo A. Assessment of coronary flow reserve by cardiac SPECT in patients with peripheral artery disease. Correlation with flow mediated dilation index. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S161 (abstract 53).

    Google Scholar 

  28. Knuuti J, Stolen KQ, Kemppainen J, Kalliokoski KK, Toikka J, Janatuinen T, Raitakari OT, Airaksinen KEJ, Nuutila P. Myocardial perfusion reserve and peripheral endothelial function are dissociated in patients with dilated cardiomyopathy. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S184–S185 (abstract 168).

    Google Scholar 

  29. Döbert N, Britten M, Berner U, Assmus B, Hamscho N, Menzel C, Schächinger V, Zaplatnikov K, Zeiher AM, Grünwald F. Progenitor cell therapy after acute myocardial infarction: assessment of myocardial viability with FDG-PET and thallium-SPECT. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S170 (abstract 93).

    Google Scholar 

  30. Ginj M, Chen J, Reubi JC, Maecke HR. Preclinical evaluation of new and highly potent analogs of octreotide for targeted radiotherapy. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S198–199 (abstract 240).

    Google Scholar 

  31. Bouziotis P, Fani M, Koumarianou E, Loudos G, Bicknell R, Harris AL, Xanthopoulos S, Stratis N, Archimandritis SC, Varvarigou AD. Lutetium-177-labeled anti-VEGF monoclonal antibody as a possible radiotherapeutic agent. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S319 (abstract P386).

    Google Scholar 

  32. Miyagawa M, Simoes MV, Städele C, Haubner R, Linke W, Reder S, Lehner T, Gansbacher B, Schwaiger M, Anton M, Bengel FM. PET Assessment of [124I]-FIAU kinetics in rats following cardiac adenoviral transfer of the herpesviral thymidinekinase reporter gene (HSV1-tk). Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S192–193 (abstract 209).

    Google Scholar 

  33. Boerman OC, Frienlink C, Dijkgraaft I, Oyen WJG, Harris TD, Edwards DS, Kuesters B, Leenders WP, Corstens FHM. An In-111-labeled quinolone targeting alfa-v-beta-3 integrin expressed on tumor cells. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S191 (abstract 201).

    Google Scholar 

  34. Kopka K, Breyholz HJ, Wagner S, Riemann B, Guilbert B, Schober O, Schaefers M. Development of new radioiodinated MMP inhibitors for in vivo imaging of atherosclerosis. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S175–176 (abstract 123).

    Google Scholar 

  35. Schipper ML, Weber A, Béhé M, Joba W, Göke R, Heufelder AE, Behr TM. In vitro therapy of neuroendocrine tumour cells with 131 iodide after transfer of the Na/I symporter gene. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S225 (abstract 366).

    Google Scholar 

  36. Aloj L, Panico MR, D’Andrea LD, Testa I, Caraco C, Arra C, Affuso A, Del Vecchio S, Pedone C, Salvatore M. In vivo and in vitro characterization of histidine tagged CCK8 labeled with99mTc-tricarbonyl. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S183 (abstract 161).

    Google Scholar 

  37. Deichen JT, Prante O, Hocke C, Maschauer S, Papadopoulos T, Kuwet T. Influence of thyroid-stimulating hormone on uptake of [18F]fluorodeoxyglucose in human thyroid in vitro. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S185 (abstract 173).

    Google Scholar 

  38. Pagani MME, Gardner A, Salmaso D, Sanchez-Crespo A, Jonsson C, Jacobsson H, Hällström T, Larsson SA. Effect of gender on cerebral hemispheres and lobes uptake in 183 subjects examined at rest by 99m-Tc-HMPAO SPET. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S198 (abstract 236).

    Google Scholar 

  39. Inoue K, Goto R, Nakagawa M, Kinomura S, Fukuda H. Age and gender effects on brain perfusion SPET with MR-based partial volume correction. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S293–294 (abstract P252).

    Google Scholar 

  40. O’Brien JT, Colloby SJ, Fenwick JD, Williams ED, Firbank MJ, Burn DJ, McKeith IG. Dopamine transporter loss visualised with I-123 FP-CIT SPECT in dementia with Lewy bodies. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S223 (abstract 355).

    Google Scholar 

  41. Vander Borght T, Tolosa E, on behalf of the DaTSCAN CUPS Study Group. SPECT using123I-ioflupane (DaTSCAN TM) in clinically uncertain parkinsonian syndromes leads to significant changes in clinical diagnosis. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S156 (abstract 29).

    Google Scholar 

  42. Kanayama Y, Amano R, Washiyama K, Irie T, Enomoto S, Kawai K, Tonami N. Olfactory transport of86Rb and 201Tl by intranasal administration—animal experiment. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S296 (abstract P266).

    Google Scholar 

  43. Pauli S, Halldin C, Farde L. Volume rendering of [11C]PE2I binding to the dopamine transporter in monkey and human brain. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S165 (abstact 74).

    Google Scholar 

  44. Otte A, Hilliard B, Taylor K, Rubens R. The intracranial distribution of eletriptan: a combined [11C]-eletriptan/[15O]-CO/[15O]-H2O positron emission tomography (PET) study. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S292 (abstract P243).

    Google Scholar 

  45. Peremans K, Audenaert K, Hoybergs Y, Jacobs F, Blanckaert P, Verschooten F, van Bree H, Slegers G, Dierckx R. Regional cerebral bloodflow and binding index of the 5-Ht2A receptor in the impulsive aggressive dog treated with citalopram. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S397 (abstract P815).

    Google Scholar 

  46. Mateos JJ, Lomeña F, Parellada E, Font M, Fernandez E, Bernardo M, Pavia J, Falcó C, Prats A, Bargalló N, Ros D. Decrease of dopamine transporter density, using [123I] FP-CIT, in first-episode schizophrenic patients presenting with parkinsonism after 3 weeks of risperidone treatment. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S215 (abstract 313).

    Google Scholar 

  47. Joe AY, Zobel A, Reinhardt MJ, Palmedo H, Reichmann K, Maier W, Biersack HJ. Cerebral blood flow alterations induced by vagus nerve stimulation in patients with treament-resistant depression. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S214 (abstract 309).

    Google Scholar 

  48. Roiz C, Suárez J, Núñez R, Domínguez L, Bernardo L, Fernández J, Alvarez C, Alvarez A, Carreño E, Llana B, F-Raigoso P, Allende T. Efficacy of radiation synovectomy with Y-90 in chronic knee joint synovitis. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S351 (abstract P558).

    Google Scholar 

  49. Zouboulis PE, Papas M, Apostopoulos DJ, Megas P, Lakiotis V, Adamopoulos C, Lambiris E, Vassilakos PJ. Yttrium-90 radiochemical synovectomy in idiopathic osteoarthritis of the knee joint. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S207 (abstract 272).

    Google Scholar 

  50. Luo QY, Chen LB, Zhu RS. Experimental study of the preventive role of palladium-103 radioactive stents on restenosis in rabbit iliac arteries. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S188 (abstract 186).

    Google Scholar 

  51. Wang SJ, Lin WY, Kwan PC. Histologic study of effect of irradiation with Re-188 solution-filled balloon in rabbit abdominal aorta. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S343–344 (abstract P519).

    Google Scholar 

  52. Kwekkeboom DJ, Bakker WH, Teunissen JJM, Kooij PPM, Krenning EP. Treatment with Lu-177-DOTA-Tyr3-octreotate in patients with neuroendocrine tumors: interim results. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S231–232 (abstract P391).

    Google Scholar 

  53. Chen LB. Radioiodide uptake in melanoma cells after transfer of human NaI symporter gene. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S173 (abstract 111).

    Google Scholar 

  54. Palmedo H, Manka-Waluch A, Albers P, Schmidt-Wolf IGH, Reinhardt M, Ezzidin S, Joe A, Roedel R, Fimmers R, Knapp FF, Guhlke S, Biersack HJ. Repeated bone targeted therapy for hormone-refractory prostate carcinoma: randomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 HEDP. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S206 (abstract 267).

    Google Scholar 

  55. Zielhuis SW, Seppenwoolde JH, van het Schip AD, Zonnenberg BA, Nijsen JFW. Experimental characterization of relaxation properties of lanthanide-loaded microspheres for the internal radionuclide therapy of liver tumors. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S220 (abstract 338).

    Google Scholar 

  56. Behe M, Schurrat T, Schramm N, Ebel G, Alfke H, Engeland U, Klose KJ, Nock B, Maina T, Behr TM. Mouse molecular imaging with a high resolution SPECT camera and fused MRT images. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S207–208 (abstract 277).

    Google Scholar 

  57. Rousseau J, Huglo D, Gancel M, Vermandel M, Hossein-Foucher C, Marchandise X. A new wireless nuclear intra-operative probe: design and performances. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S224 (abstract 360).

    Google Scholar 

  58. Mari C, Yamaguchi Y, Ghazarossian V, Patt B, Blankenberg F, Strauss HW. Utility of a thin-flexible β-sensitive intravascular catheter to detect increased metabolic activity in atherosclerotic plaques. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S178–179 (abstract 137).

    Google Scholar 

  59. Livieratos L, Rajappan K, Bailey D, Rimoldi O, Camici P. Respiratory gating of cardiac PET data. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S174 (abstract 115).

    Google Scholar 

  60. Lassmann M, Goulko G, Hänscheid H, Luster M, Reiners C. How effective is thyroid blockage after application of stable iodine or perchlorate? Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S209–210 (abstract 287).

    Google Scholar 

  61. Barone R, Walrand S, Leveque P, Pauwels S, Jamar F. Red marrow toxicity after therapy with radiolabelled somatostatin analogues: a possible role of plasma protein binding. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S232 (abstract 395).

    Google Scholar 

  62. Kobylecka M, Chudzinski W, Miskiewicz J, Kunikowska J, Bajera A, Krolicki L. No prolonged MIBI retention? A study of 82 enlarged parathyroid glands. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S186–187 (abstract 179).

    Google Scholar 

  63. Rubello D, Piotto A, Toniato A, Pelizzo MR, Giannini S, Muzzio PC, Sotti G, Casara D. Role of hand-held gamma probe and low99mTc-MIBI dose in performing minimally invasive parathyroidectomy. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S187 (abstract 183).

    Google Scholar 

  64. Bozkurt MF, Ugur O, Volkan B, Ozcan P, Hamaloglu E, Konan A, Sayek I. Patient specific protocol for the optimization of gamma probe-guided parathyroidectomy. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S187 (abstract 181).

    Google Scholar 

  65. Nagabhushan N, Syed R, Gacinovic S, Flavia FRG, Zanoni P, Costa DC, Shah PJ, Neild G, Bomanji JB.99mTc-MAG3: a diagnostic technique to evaluate critical bladder volumes in neuropathic bladders. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S179–180 (abstract 143).

    Google Scholar 

  66. Bleeker-Rovers CP, Bredie SJH, van der Meer JWM, Corstens FHM, Oyen WJG. The value of 18-F-fluorodeoxyglucose positron emission tomography in patients with fever of unknown origin. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S196 (abstract 228).

    Google Scholar 

  67. Love C, Marwin SE, Tomas MB, Tronco GG, Palestro CJ. A comparison of FDG and sequential bone-gallium imaging for diagnosing the infected joint prosthesis. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S231 (abstract 390).

    Google Scholar 

  68. Obradovic V, Artiko V, Petrovic N, Davidovic B, Vucetic C, Nikolic N, Djokic D, Jankovic D. Detection of orthopedic infections using99mTc-ciprofloxacin prepared by new developed procedure. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S230 (abstract 385).

    Google Scholar 

  69. Desypris G, Limoges R, Riddoch B, Bump E, Siaens R, Slegers G. The effect of dilution of reconstituted INFECTONTM on whole body biodistribution and uptake at site of infection in the rat. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S378 (abstract P712).

    Google Scholar 

  70. Rubello D, Maran A, Avogaro A, Tiengo A, Muzzio PC, Casara D. Interpretation scan criteria of Leukoscan imaging in diagnosing peripheral bone infection. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S230 (abstract 384).

    Google Scholar 

  71. Martin-Comin J, Soroa VE, Rabiller G, Velazquez MH, Cuesta L, Roca M.99mTc-ceftizoxime scintigraphy in the diagnosis of infection. First clinical experience. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S376 (abstract P701).

    Google Scholar 

  72. Montravers F, Landman-Parker J, Grahek D, Kerrou K, Aide N, Younsi N, Leverger G, Talbot JN. Impact of FDG-PET on staging and management in childhood lymphoma: a three-year experience. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S194 (abstract 219).

    Google Scholar 

  73. Tarján T, Várkonyi, Papós M, Németh P, Lázár M, Kukla E, Makula É, Csernay L, Pávics L. Diagnostic value of the leukocyte scintigraphy in paediatric patients with inflammatory bowel disease. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S212–213 (abstract 302).

  74. Suárez J, Zeidan N, Domínguez L, Bernardo L, Alvarez A, Roiz C, F-Raigoso P, Llana B, Nuñez R, Allende T, Bousoño C, Ramos E, González N. Inflammatory bowel disease in children: diagnosis and follow up with99mTc-HMPAO labeled leukocytes scintigraphy. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S373 (abstract P683).

    Google Scholar 

  75. Quigley AM, Buscombe JR, Hilson AJW.99mTc HMPAO white cell scans in paediatric inflammatory bowel disease cannot be used alone. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S373–374 (abstract P685).

    Google Scholar 

  76. Valenza V, Perotti G, Samanes Gajate AM, Di Giuda D, D’Errico G, Porziella V, Marchese M, Granone P, Troncone L. Esophageal scintigraphy in achalasia: analysis before and after myotomy. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S370 (abstract P665).

    Google Scholar 

  77. Arslandemir C, Hetzel M, Nuessle K, Buck AK, Reske SN, Schirrmeister H. Omitting bone scanning according to staging guidelines leads to futile therapy in lung cancer. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S234 (abstract 404).

    Google Scholar 

  78. Baum RP, Schmuecking M, Niesen A, Ruhwedel H, Boehm H, Schalldach U. Is there a role of F-18-fluoride ion PET for early diagnosis and evaluation of therapeutic outcome of heterotopic ossification after recent paraplegia due to spinal cord injury? Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S208 (abstract 281).

    Google Scholar 

  79. Ogura Y, Narabayashi I, Utsunomiya K, Komori T, Adachi I, Stundzia A, Dufort P. Lung image fusion CT with SPECT of ventilation-perfusion scan: a rapid 3D nonlinear method using energy minimization. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S329 (abstract P441).

    Google Scholar 

  80. Medved MM, Fidler S, Fidler V. Development of telemedicine software for efficient low-cost communication. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 2):S395 (abstract P807).

    Google Scholar 

Download references

Acknowledgements

Important and heart-felt acknowledgements are due to those who allowed me to give the highlights lecture 2003 and to prepare this manuscript. First of all, I wish to thank Profs. Peter van Rijk and Rudi Dierckx, with whom I shared joy and pain in preparing the lecture; Prof. Francesco Scopinaro, Prof. Luigi Mansi and David Guidani for useful suggestions and supervision; Giovanna Kiferle and Carlo Moiso for all their wonderful support; my co-workers Marco Chianelli, Alessio Annovazzi, Gabriela Capriotti, Gemma Parisella, Federica Corsetti, Calogero D’Alessandria and Bieke van den Bossche, who performed a huge amount of work; and my secretary, Claudia Moricca, without whom this work would not have been possible. Finally, I wish to thank my wife, Maria Luisa, for the love and patience she showed for me during the preparation of the lecture.

Author information

Authors and Affiliations

  1. Nuclear Medicine, Department of Clinical Sciences, 2nd Faculty of Medicine, University “La Sapienza”, 00161, Rome, Italy

    Alberto Signore

Authors
  1. Alberto Signore
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alberto Signore.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Signore, A. Highlights of the Annual Congress of the European Association of Nuclear Medicine, Amsterdam 2003. Eur J Nucl Med Mol Imaging 31, 439–458 (2004). https://doi.org/10.1007/s00259-004-1454-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-004-1454-8

Keywords

Search

Navigation